Abstract -The methyl 3-amino-6-bromothieno[3,2-b]pyridine-2-carboxylate, recently reported by some of us, was reacted in Sonogashira couplings with several (hetero)arylacetylenes. The growth inhibitory activity of the novel methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates obtained was evaluated on three human tumor cell lines (MCF-7, NCI-H460, A375-C5). The para-methoxyphenyl and the ortho and para-aminophenyl derivatives were the most promising compounds, and their effects were further studied regarding alterations in the normal cell cycle distribution and induction of apoptosis in the NCI-H460 cell line. All three compounds altered cell cycle distribution and the ortho-aminophenyl derivative was further shown to induce apoptosis in the same cell line.
Introduction
Recently several thieno [3,2-b] pyridines have shown important biological activities, namely antitumor and antiangiogenesis or dual activity, essentially by acting as inhibitors of tyrosine kinase receptors I [1] , II [2] III [3] , or nonreceptors (IV) [4] which have been implicated in the growth and progression of various human cancers and, therefore, have been crucial in the development of anticancer therapies. carboxylate [5] it was decided to use it in the Pd/Cu-catalysed Sonogashira coupling [6] with several terminal (hetero)arylacetylenes in the synthesis of novel methyl 3-amino-6- For the most promising compounds the effects on the cell cycle distribution and induction of apoptosis were studied, in order to investigate their possible mechanisms of action.
Results and discussion

Synthesis
The 6-bromothieno[3,2-b]pyridine 1 [5] was used as the thieno [3,2-b] pyridine component in the Pd/Cu catalyzed Sonogashira reaction [5] [6] [7] with several (hetero)arylacetylenes to obtain the novel methyl 3-amino-6-[(hetero)arylethynyl]thieno [3,2-b] pyridine-2-carboxylates 2a-m in high to excellent yields using the conditions depicted in Scheme 1, already used by us in the synthesis of arylethynyl benzo [b] thiophene derivatives [7] . 
Growth inhibition of human tumor cell lines
The in vitro growth inhibitory activity of all the compounds prepared was evaluated using three human tumor cell lines, representing different tumor types, namely breast adenocarcinoma (MCF-7), melanoma (A375-C5), and non-small cell lung cancer (NCI-H460), after a continuous exposure of 48 h. The results are summarized in Table 1 . a The lowest concentrations causing 50% of cell growth inhibition (GI 50 ) after a continuous exposure of 48 h, expressed as means ± SEM of three independent experiments performed in duplicate. b Due to the low solubility of the compound in DMSO the maximum concentration tested was lower than 150 µM. Doxorubicin was used as positive control (GI50: MCF-7 = 43.3 ± 2.6 nM; A375-C5 = 130.2 ± 10.1 nM; NCI-H460 = 35.6 ± 1.6 nM).
From the analysis of Table 1 it can be concluded that the p-methoxylated compound 2d presents the lowest GI 50 values (below 1.0 µM), with marked selectivity for MCF-7 and NCI-H460 cell lines. The aminated compounds 2e-2g were also effective at inhibiting cell growth, with GI 50 values between 2.6-11.6 µM for the three cell lines, the best being the o-and p-aminophenyl compounds 2e and 2g.
The methoxylated compounds 2b and 2c were not very potent at inhibiting cell growth. Considering the fact that the unsubstituted phenylacetylene derivative 2a did not show any activity at the highest tested concentration, the cell growth inhibitory activity presented by the compounds discussed above appears to be closely dependent on the substitution pattern.
The pyridine derivative 2k shows some selectivity against A375-C5 cell line, with a GI 50 value of 13.9 µM. The position of the C-C bond in the pyridine ring appears to be determinant for the cell growth inhibitory activity, since compound 2l was not active at the highest concentration tested.
The thiophene derivative 2m presents moderate growth inhibitory activity against the three cell lines in study (GI 50 values between 24.8-29.6 µM).
Cell cycle analysis and detection of apoptosis
The most active compounds were chosen to be further investigated regarding their mechanism of action. The NCI-H460 cell line was incubated with the GI 50 concentrations of compounds 2d, 2e and 2g for 48 h and their effects on the normal cell (Table 2) . From these results it appears that compounds 2d and 2g induce a cell cycle arrest on phases G0/G1, whereas compound 2e appears to cause a G2/M cell cycle arrest. These compounds were also shown to induce apoptosis, as determined by the annexin V-FICT/PI flow cytometry assay, particularly compound 2e ( Table 2 ). This observation was confirmed by the presence of a sub-G1 peak in the cell cycle profile analysis (indicative of DNA degradation, characteristic of apoptosis) upon incubation with compound 2e (data not shown).
Table2. Cell cycle analysis (% of cells in phases G0/G1, S, G2/M) and % of NCI-H460 cells undergoing apoptosis after a 48 h treatment with compounds 2d, 2e and 2g at their GI 50 concentrations.
G0/G1
(cells %)
S (cells %)
G2/M (cells %)
Apoptosis (cells %)
Control 57.1 ± 1.6 28.2 ± 1.4 14.7 ± 0.9 11.7 ± 1.6 DMSO 55.1 ± 1.0 28. 68.0 ± 0.7 18.6 ± 0.8 13.4 ± 0.6 17.0 ± 2.1
Untreated cells were used as the control and a solvent control (DMSO) was also included. Results are the mean ± standard error of three to six independent experiments performed in duplicate.
a Apoptosis induction by compound 2e was statistically significantly when compared to the control (P <0.05).
According to these findings, the compounds are likely to present different mechanisms of action. The effect of compound 2e in cell growth inhibition seems to be due to the induction of both apoptosis and cell cycle arrest in the G2/M phase (Table2).
Compounds 2d and 2g did not cause such a marked induction of apoptosis (Table 2 ) and thus their growth inhibitory effects seem to be mainly due to cell cycle related events.
Conclusion
Novel methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates were synthesized and tested for their in vitro growth inhibitory activity on three human tumor cell lines. All compounds were fully soluble at the GI 50 concentration. Overall, the para-methoxyphenyl and the ortho and para-aminophenyl derivatives are the most promising compounds, presenting very low GI 50 values and therefore their effects on cell cycle distribution and induction of apoptosis were further investigated in the NCI-H460 cell line. Compounds 2d, 2e and 2g had an effect on cell cycle distribution, with a G0/G1 arrest being detected for the para-methoxyphenyl and the para-aminophenyl derivatives and a G2/M arrest for the ortho-aminophenyl derivative. Additionally, the ortho-aminophenyl compound was found to significantly induce apoptosis at the GI 50 concentration in the tested cell line. Hence, at least two mechanisms of action appear to be involved in the activity of this compound, cell cycle related events and induction of apoptosis. The obtained data suggest that the results are dependent on the compound substitution pattern, nevertheless it is important to bear in mind that the physical properties of the compounds, particularly cell permeability, may be influencing their relative activity.
Experimental 4.1 Synthesis
Melting points ( o C) were determined in a SMP3 Stuart apparatus and are uncorrected. H and 13 C NMR spectra were recorded on a Varian Unity Plus at 300 and 75.4 MHz, and on a Bruker Avance II at 400 and 100.6 MHz, respectively. Heteronuclear correlations, 1 H-13 C, HMQC or HMSQ and HMBC were performed to attribute some signals. MS (EI) and HRMS data were recorded by the mass spectrometry service of the University of Vigo, Spain. Elemental analysis was performed on a LECO CHNS 932 elemental analyser. The reactions were monitored by thin layer chromathography (TLC). Dry flash was performed on Macherey-Nagel silica gel 150-230 mesh. Petroleum ether refers to the boiling range 40-60 o C. Ether refers to diethylether.
General procedure for the synthesis of compounds 2a-2m:
Compound 1 (150 mg, 0.540 mmol), the (hetero)arylacetylene (1.1 equiv.), PdCl 2 (PPh 3 ) 2 (5 mol%), CuI (3 mol%), and NEt 3 (3 equiv.) were added to dry DMF (2-3 mL) into a dry Schlenk tube, under argon, and the mixture was heated with stirring at 100 ºC for 1.5 h. After cooling, water (5 mL) and ethyl acetate (5 mL) were added and the phases were separated. The aqueous phase was then extracted with additional ethyl acetate (3 × 5 mL). The organic phases were collected, dried (MgSO 4 ), filtered, and, finally, removal of the solvent under reduced pressure gave a solid which was submitted to column chromatography using 50% ether/ petroleum ether as eluent. The solid obtained was washed with petroleum ether and fully characterized. 
Solutions of the compounds
Stock solutions of the tested compounds were prepared in DMSO and kept at −70°C. Appropriate dilutions were freshly prepared in the test medium just prior to the assays. The effect of the vehicle solvent (DMSO) on the growth of the cell lines was evaluated by exposing untreated control cells to the maximum concentration of DMSO used in the assays (0.25%). No influence was found (data not shown).
Cell cultures
Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 (melanoma) were used. MCF-7 and A375-C5 were obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK), and NCI-H460 was kindly provided by the National Cancer Institute (NCI, Bethesda, USA). They were routinely maintained as adherent cell cultures in RPMI-1640 medium supplemented with 5% heat-inactivated FBS, 2 mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 µg/mL), at 37°C in a humidified atmosphere containing 5% CO 2 . Exponentially growing cells were obtained by plating 1.5×10 5 cells/mL for MCF-7 and 0.75×10 5 cells/mL for A375-C5 and NCI-H460, followed by a 24-h incubation.
Growth inhibition assay
The effects on the in vitro growth of human tumor cell lines were evaluated according to the procedure adopted by the NCI (USA) in their "In vitro Anticancer Drug Discovery Screen", using the proteinbinding dye sulforhodamine B to assess cell growth. [8, 9] Briefly, exponentially growing cells were exposed for 48 h, in 96-well microtiter plates, to five serial dilutions of each test compound, starting from a maximum concentration of 150 µM (if possible). Following the exposure period adherent cells were fixed in situ with TCA, washed and stained with SRB. The bound stain was solubilized and the absorbance was measured at 492 nm in a plate reader (Bio-tek Instruments Inc., Powerwave XS, Wincoski, USA). Dose-response curves were obtained for each test compound and cell line, and the growth inhibition of 50% (GI 50 ), corresponding to the concentration of the compounds that inhibited 50% of the net cell growth was calculated as described elsewhere. [9] Doxorubicin was tested in the same manner, to be used as a positive control.
Flow cytometric assays for cell cycle distribution analysys and apoptosis detection with annexin V-FITC/PI assay
NCI-H460 cells were plated at 0.75×10 5 cells/mL in 6-well plates and left incubating for 24 h. Cells were then incubated with complete medium only (control), medium with the compound's solvent (DMSO) or with compounds 2d, 2e and 2g at their respective GI 50 concentrations previously obtained by the SRB assay (0.32, 5.7 and 8.9 µM). Cells were harvested following a 48 h incubation with the compounds and further processed for either cell cycle analysis or apoptosis detection. For cell cycle analysis, cells were fixed in 70 % ethanol and subsequently resuspended in PBS containing 0.1 mg/mL RNase A and 5 µg/mL propidium iodide, prior to analysis. Induced apoptosis was assayed by the Human Annexin V-FITC/PI apoptosis Kit (Bender MedSystems, Vienna, Austria) according to the manufacturer's instructions. [10] Cellular DNA content (for cell cycle distribution analysis and presence of sub-G1 peak, suggestive of apoptosis induction) and measurement of phosphatidylserine externalization were analyzed using an Epics XL-MCL Coulter flow cytometer plotting at least 20,000 events per sample. Cell cycle distribution and apoptosis data analysis was subsequently performed using FlowJo 7.2 software (Tree Star, Inc.). Experiments were performed in duplicate in three to six independent occasions and the average and standard error of the obtained results were presented. Statistical analysis was performed for the induction of apoptosis results by the non-parametric Friedman's test followed by Dunn's Post-test using GraphPad Prism 5 software. P values < 0.05 were considered as statistically significant.
